文献
J-GLOBAL ID:201202205626421650
整理番号:12A1434335
適応的使用許可: 薬物承認の進歩の点で次の段階に進む
Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval
著者 (27件):
EICHLER H-G
(European Medicine Agency, London, GBR)
,
EICHLER H-G
(MIT Center for Biomedical Innovation, Massachusetts, USA)
,
OYE K
(MIT Center for Biomedical Innovation, Massachusetts, USA)
,
OYE K
(MIT Dep. of Political Sci., Massachusetts, USA)
,
OYE K
(MIT Div. of Engineering Systems, Massachusetts, USA)
,
BAIRD LG
(MIT Center for Biomedical Innovation, Massachusetts, USA)
,
ABADIE E
(Agence Francais de Securite Sanitaire des Produits de Sante, Saint Denis, FRA)
,
BROWN J
(Harvard Medical School, Massachusetts, USA)
,
DURM CL
(MIT Center for Biomedical Innovation, Massachusetts, USA)
,
FERGUSON J
(Novartis Vaccines & Diagnostics, Massachusetts, USA)
,
GARNER S
(National Inst. for Health and Clinical Excellence, London, GBR)
,
GARNER S
(Commonwealth Fund, New York, USA)
,
HONIG P
(AstraZeneca, London, GBR)
,
HUKKELHOVEN M
(Bristol-Myers Squibb, New York, USA)
,
LIM JCW
(Singapore Health Sci. Authority, SGP)
,
LIM R
(Health Canada, Ontario, CAN)
,
LUMPKIN MM
(US Food and Drug Administration, Maryland, USA)
,
NEIL G
(Johnson&Johnson, New Jersey, USA)
,
O’ROURKE B
(Canadian Agency for Drugs and Technol. in Health, Ontario, CAN)
,
PEZALLA E
(Aetna, Connecticut, USA)
,
SHODA D
(Pfizer, New York, USA)
,
SEYFERT-MARGOLIS V
(US Food and Drug Administration, Maryland, USA)
,
SIGAL EV
(Friends of Cancer Res., Washington, DC, USA)
,
SOBOTKA J
(Ohio Northern Univ. Raabe Coll. of Pharmacy, Ohio, USA)
,
TAN D
(Singapore Health Sci. Authority, SGP)
,
UNGER TF
(Pfizer, New York, USA)
,
HIRSCH G
(MIT Center for Biomedical Innovation, Massachusetts, USA)
資料名:
Clinical Pharmacology & Therapeutics
(Clinical Pharmacology & Therapeutics)
巻:
91
号:
3
ページ:
426-437
発行年:
2012年03月
JST資料番号:
A0721B
ISSN:
0009-9236
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)